Tadalafil 5 mg Once a Day Compared to Placebo in Improving Erectile Dysfunction and Sexual Quality of Life.

Trial Profile

Tadalafil 5 mg Once a Day Compared to Placebo in Improving Erectile Dysfunction and Sexual Quality of Life.

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Apr 2013

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Sponsors Eli Lilly; Lilly ICOS
  • Most Recent Events

    • 06 Jul 2012 New source identified and integrated (German Clinical Trials Register: DRKS00003999).
    • 09 Jun 2009 Actual patient number changed from 344 to 342 as reported by ClinicalTrials.gov.
    • 06 May 2009 Results have been published in the May issue of Journal of Sexual Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top